Lesion depth and marrow stimulation results

• Published in: Foot and ankle surgery Vol. 29; no. 2; pp. 165 - 170
• Main Authors: Aldahshan, Wael Abdalkarim, Abdelaziz, Ashraf Mohammed, Elsherief, Faisal Ahmad, FathyElbehairy, Hassan, Elshamy, Ahmed Sayed Ahmed, Ibrahim, Mohamed Nagah Ahmed, Abd alfatah, Mohammed Ahmed
• Format: Journal Article
• Language: English
• Published: France Elsevier Ltd 01.02.2023
• Subjects: Arthroscopy; Bone Marrow - diagnostic imaging; Cartilage, Articular - surgery; Depth; Humans; Magnetic Resonance Imaging; Marrow stimulation; Osteochondral lesions of the talus; Prognostic factors; Prospective Studies; Retrospective Studies; Talus - surgery; Treatment Outcome; Marrow stimulation; Osteochondral lesions of the talus; Depth; Prognostic factors
• ISSN: 1268-7731; 1460-9584
• DOI: 10.1016/j.fas.2022.12.010

The aim of this study was to study the importance Osteochondral lesion (OCL) depth as a singular factor for treatment outcomes using marrow stimulation. We hypothesized that the clinical outcomes of marrow stimulation would be inferior for lesions with depths of more than 5 mm compared to those less than 5 mm. An interventional prospective cohort study was conducted on 55 ankles in 55 patients who had been diagnosed with full-thickness osteochondral lesions of the talus; stage II, III, IV according to Anderson staging system based on magnetic resonance imaging; depth of 10 mm or less; and area of 150 mm2 or less measured by preoperative computed tomography. According to lesion depth, patients were divided into two groups: group (A) ≤ 5 mm, and group (B) ˃ 5 mm. The mean follow-up period for both groups was 30 months (range, 22–40). For groups A and B the average preoperative Foot and Ankle Outcome Scores (FAOS) were 43.1 ± 8.8 (range, 25–52) and 46 ± 8.5 (range, 32–60), respectively, and improved to 90 ± 4.3 (range, 80–96) (P = 0.001) and 75 ± 6.4 (range, 65–88) (P = 0.001) at the final follow-up. The average time to full weight bearing was 12 weeks (range, 10–16) in group A and 16 weeks (range, 12–20) in group B. Although treatment of OCLs is still undergoing changes and there are many prognostic factors that affect outcomes during marrow stimulation treatment, depth of OCL was shown to be an independent factor affecting outcomes. OCLs of less than 5 mm in depth were more likely to have superior clinical outcomes compared to OCLs of more than 5 mm. The depth of OCL talus is an important factor as it affects the outcome of arthroscopic marrow stimulation inversely. I